Anti-phospholipase A2 receptor antibodies in recurrent membranous nephropathy

American Journal of Transplantation

Volumn 15, Issue 5, 2015, Pages 1349-1359

  Kattah, A ^a   Ayalon, R ^b   Beck, L H ^b   Sethi, S ^a   Sandor, D G ^b   Cosio, F G ^a   Gandhi, M J ^c   Lorenz, E C ^a   Salant, D J ^b   Fervenza, F C ^a  

^a MAYO CLINIC   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Neurology   (United States)

Author keywords

Clinical research; glomerular biology and disease; kidney transplantation; nephrology; practice; recurrent disease

Indexed keywords

BASILIXIMAB; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHOLIPASE A2 RECEPTOR ANTIBODY; RECEPTOR ANTIBODY; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; IMMUNOSUPPRESSIVE AGENT; PHOSPHOLIPASE A2 RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; STAINING; STEROID THERAPY; AGED; BIOPSY; CHEMISTRY; GRAFT SURVIVAL; IMMUNOLOGY; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDY; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; BIOPSY; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEINURIA; RECEPTORS, PHOSPHOLIPASE A2; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84928054346     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13133     Document Type: Article

References (26)

1. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD,. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11-21.
2. Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ,. Anti-phospholipase A(2) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2011; 6: 1286-1291.
3. Hoxha E, Harendza S, Zahner G, Panzer U, Steinmetz O, Fechner K,. An immunofluorescence test for phospholipase-A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 2011; 26: 2526-2532.
4. Debiec H, Martin L, Jouanneau C, et al. Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy. Am J Transplant 2011; 11: 2144-2152.
5. Qin W, Beck LH Jr, Zeng C, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 2011; 22: 1137-1143.
6. Oh YJ, Yang SH, Kim DK, Kang SW, Kim YS,. Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. PLoS ONE 2013; 8: e62151.
7. Svobodova B, Honsova E, Ronco P, Tesar V, Debiec H,. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Nephrol Dial Transplant 2013; 28: 1839-1844.
8. Debiec H, Ronco P,. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 2011; 364: 689-690.
9. Larsen CP, Messias NC, Silva FG, Messias E, Walker PD,. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol 2013; 26: 709-715.
10. Donadio JV Jr, Torres VE, Velosa JA, et al. Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int 1988; 33: 708-715.
11. Schieppati A, Mosconi L, Perna A, et al. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 1993; 329: 85-89.
12. Dabade TS, Grande JP, Norby SM, Fervenza FC, Cosio FG,. Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study. Am J Transplant [Research Support. Non-U.S. Gov't]. 2008; 8: 1318-1322.
13. Poduval RD, Josephson MA, Javaid B,. Treatment of de novo and recurrent membranous nephropathy in renal transplant patients. Semin Nephrol 2003; 23: 392-399.
14. El-Zoghby ZM, Grande JP, Fraile MG, Norby SM, Fervenza FC, Cosio FG,. Recurrent idiopathic membranous nephropathy: Early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies. Am J Transplant 2009; 9: 2800-2807.
15. Sprangers B, Lefkowitz GI, Cohen SD, et al. Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation. Clin J Am Soc Nephrol 2010; 5: 790-797.
16. Stahl R, Hoxha E, Fechner K,. PLA2R autoantibodies and recurrent membranous nephropathy after transplantation. N Engl J Med 2010; 363: 496-498.
17. Seitz-Polski B, Payre C, Ambrosetti D, et al. Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: A case series of 15 patients. Nephrol Dial Transplant 2014; Jul 25.
18. Rodriguez EF, Cosio FG, Nasr SH, et al. The pathology and clinical features of early recurrent membranous glomerulonephritis. Am J Transplant 2012; 12: 1029-1038.
19. Timmermans SA, Damoiseaux JG, Heerings-Rewinkel PT, et al. Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: A cohort study. Am J Clin Pathol 2014; 142: 29-34.
20. Huang CC, Lehman A, Albawardi A, et al. IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. Mod Pathol 2013; 26: 799-805.
21. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ,. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002; 347: 103-109.
22. Cosyns JP, Couchoud C, Pouteil-Noble C, Squifflet JP, Pirson Y,. Recurrence of membranous nephropathy after renal transplantation: Probability, outcome and risk factors. Clin Nephrol 1998; 50: 144-153.
23. Monga G, Mazzucco G, Basolo B, Quaranta S, Motta M, Segoloni G,. Membranous glomerulonephritis (MGN) in transplanted kidneys: Morphologic investigation on 256 renal allografts. Mod Pathol 1993; 6: 249-258.
24. El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009; 9: 527-535.
25. Andresdottir MB, Wetzels JF,. Increased risk of recurrence of membranous nephropathy after related donor kidney transplantation. Am J Transplant 2012; 12: 265-266.
26. Netzer KO, Merkel F, Weber M,. Goodpasture syndrome and end-stage renal failure-to transplant or not to transplant? Nephrol Dial Transplant 1998; 13: 1346-1348.